Measuring plasma estradiol levels in in vitro fertilization. Is it useful?;¿Es útil medir el nivel de estradiol plasmático en fecundación in vitro?

Revista Iberoamericana de Fertilidad y Reproduccion Humana

Volumn 27, Issue 1, 2010, Pages 43-49

  Aguirre, Salvador García ^a   Hevia, Ignacio González ^a   García Carpintero, Gloria ^a   Del Rosal, Ma Josefa ^a  

^a Unidad de Cirugía Laparoscópica de la Obesidad y el Metabolismo UCLOM   (Spain)

Author keywords

Estradiol; In vitro fertilization; Transvaginal ultrasound scan

Indexed keywords

ESTRADIOL; FOLLITROPIN; LEUPRORELIN; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; BODY MASS; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; OOCYTE; PREGNANCY RATE; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; TRANSVAGINAL ECHOGRAPHY;

EID: 77956708362     PISSN: 11320249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Quigley MM, Sokoloski JE, Richards SI.: Timing human chorionic gonadotropin administration by days of estradiol rise. Fertil Steril. 1985, Dec; 44(6): 791-5.
2. Lass A.: Monitoring of in vitro fertilization-embryo transfer cycles by ultrasound versus by ultrasound and hormonal levels: a prospectre, multicenter, randomized study. Fertil Steril. 2003 Jul; 80(1): 80-5.
3. Hurst BS, Tucker KE, Schlaff WD.: A minimally monitored assisted reproduction stimulation protocol reduces cost without compromising success. Fertil Steril. 2002 Jan; 77(1): 98-100.
4. Thomas K, Searle T, Quinn A, Wood S, Lewis-Jones I, Kingsland C.: The value of routine estradiol monitoring in assisted conception cycles. Acta Obstet Gynecol Scand. 2002 Jun; 81(6): 551-4.
5. Al-Shawaf T, Zosmer A, Hussain S, Tozer A, Panay N, Wilson C, et al.: Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients. Hum Reprod. 2001 Jan;16(1): 24-30.
6. Noyes N, Hampton BS, Berkeley A, Licciardi F, Grifo J, Krey L.: Factors useful in predicting the success of oocyte donation: a 3-year retrospective analysis. Fertil Steril. 2001 Jul; 76(1): 92-7.
7. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al.: Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006 Jan; 85(1): 112-20.
8. Roest J, Verhoeff A, van Heusden AM, Zeilmaker GH.: Minimal monitoring of ovarian hyperstimulation: a useful simplification of the clinical phase of in vitro fertilization treatment. Fertil Steril. 1995 Sep; 64(3): 552-6.
9. Wikland M, Borg J, Hamberger L, Svalander P.: Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Hum Reprod. 1994 Aug; 9(8): 1430-6.
10. Aboulghar M.: Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod. 2003 Jun; 18(6): 1140-1.
11. Sharara FI, McClamrock HD.: High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil Steril. 1999 Sep; 72(3): 401-5.
12. Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH.: Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril. 1998 Mar; 69(3): 505-10.
13. Hendriks DJ, Klinkert ER, Bancsi LF, Looman CW, Habbema JD, te Velde ER, et al.: Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF). J Assist Reprod Genet. 2004 Mar; 21(3): 65-72.
14. Chen Y, Yu Q, Zhang YW, He FF, Sun ZY.: Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle. Zhonghua Fu Chan Ke Za Zhi. 2006 Jun; 41(6): 368-71.
15. Bahceci M, Ulug U, Turan E, Akman MA.: Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist. Eur J Obstet Gynecol Reprod Biol. 2007 Jan; 130(1): 93-8.
16. Vladimirov I, Tacheva D, Blagoeva V.: Prognostic value of some hormonal and ultrasound ovarian reserve tests. Akush Ginekol (Sofiia). 2003; 42(5): 14-20.
17. Friedler S, Zimerman A, Schachter M, Raziel A, Strassburger D, Ron El R.: The midluteal decline in serum estradiol levels is drastic but not deleterious for implantation after in vitro fertilization and embryo transfer in patients with normal or high responses. Fertil Steril. 2005 Jan; 83(1): 54-60.
18. Meyer WR, Beyler SA, Baker ST, Somkuti SG, Lowden DA, Grainger DA.: Value of estradiol response after human chorionic gonadotropin administration in predicting in vitro fertilization success. Fertil Steril. 1999 Sep; 72(3): 542-5.
19. Forman RG, Robinson J, Egan D, Ross C, Gosden B, Barlow DH.: Follicular monitoring and outcome of in vitro fertilization in gonadotropin-releasing hormone-agonist-treated cycles. Fertil Steril. 1991 Mar; 55(3): 567-73.
20. Vlaisavljevic V, Kovacic B, Reljic M, Lovrec VG.: Three protocols for monitoring follicle development in 587 unstimulated cycles of in vitro fertilization and intracytoplasmic sperm injection. A comparison. J Reprod Med. 2001 Oct; 46(10): 892-8.
21. Murad NM.: Ultrasound or ultrasound and hormonal determinations for in vitro fertilization monitoring. Int J Gynaecol Obstet. 1998 Dec; 63(3): 271-6.
22. Kyrou D, Popovic-Todorovic B, Fatemi HM, Bourgain C, Haentjens P, Van Landuyt L, Devroey P.: Does the estradiol level on the day of human chorionic gonadotropin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH anatgonist?. Human reprod. Advance acces published August 11, 2009.
23. Kwan I, Bhattacharya S, McNeil A, van Rumste MM.: Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI). Cochrane Database Syst Rev. 2008(2): CD005289.